These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

597 related articles for article (PubMed ID: 31823961)

  • 21. M6A-related bioinformatics analysis reveals that HNRNPC facilitates progression of OSCC via EMT.
    Huang GZ; Wu QQ; Zheng ZN; Shao TR; Chen YC; Zeng WS; Lv XZ
    Aging (Albany NY); 2020 Jun; 12(12):11667-11684. PubMed ID: 32526707
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The pan-cancer analysis of the two types of uterine cancer uncovered clinical and prognostic associations with m6A RNA methylation regulators.
    Zou Z; Zhou S; Liang G; Tang Z; Li K; Tan S; Zhang X; Zhu X
    Mol Omics; 2021 Jun; 17(3):438-453. PubMed ID: 34110327
    [TBL] [Abstract][Full Text] [Related]  

  • 23. m6A RNA methylation regulators play an important role in the prognosis of patients with testicular germ cell tumor.
    Cong R; Ji C; Zhang J; Zhang Q; Zhou X; Yao L; Luan J; Meng X; Song N
    Transl Androl Urol; 2021 Feb; 10(2):662-679. PubMed ID: 33718069
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Construction and Validation of an m6A RNA Methylation Regulators-Based Prognostic Signature for Esophageal Cancer.
    Xu LC; Pan JX; Pan HD
    Cancer Manag Res; 2020; 12():5385-5394. PubMed ID: 32753956
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of an eight-m6A RNA methylation regulator prognostic signature of uterine corpus endometrial carcinoma based on bioinformatics analysis.
    Miao C; Fang X; Chen Y; Zhao Y; Guo Q
    Medicine (Baltimore); 2021 Dec; 100(49):e27689. PubMed ID: 34889221
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comprehensive characterization of tumor microenvironment and m6A RNA methylation regulators and its effects on PD-L1 and immune infiltrates in cervical cancer.
    Ji H; Zhang JA; Liu H; Li K; Wang ZW; Zhu X
    Front Immunol; 2022; 13():976107. PubMed ID: 36091006
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development and Validation of an m6A RNA Methylation Regulator-Based Signature for Prognostic Prediction in Cervical Squamous Cell Carcinoma.
    Pan J; Xu L; Pan H
    Front Oncol; 2020; 10():1444. PubMed ID: 32974164
    [No Abstract]   [Full Text] [Related]  

  • 28. m
    Zhuang J; Lin C; Ye J
    J Cell Physiol; 2020 Sep; 235(9):6300-6306. PubMed ID: 32043594
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Potential role of m6A RNA methylation regulators in osteosarcoma and its clinical prognostic value.
    Liu H; Qin G; Ji Y; Wang X; Bao H; Guan X; Wei A; Cai Z
    J Orthop Surg Res; 2021 May; 16(1):294. PubMed ID: 33952279
    [TBL] [Abstract][Full Text] [Related]  

  • 30. m6A regulators are differently expressed and correlated with immune response of pancreatic adenocarcinoma.
    Zhang T; Sheng P; Jiang Y
    J Cancer Res Clin Oncol; 2023 Jul; 149(7):2805-2822. PubMed ID: 35780396
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development and Validation of an m6A RNA Methylation Regulators-Based Signature for Predicting the Prognosis of Adrenocortical Carcinoma.
    Shen C; Liu J; Yang X; Jiao W; Wang Y
    Front Endocrinol (Lausanne); 2021; 12():568397. PubMed ID: 33692753
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression pattern and prognostic value of N6-methyladenosine RNA methylation key regulators in hepatocellular carcinoma.
    Deng M; Fang L; Li SH; Zhao RC; Mei J; Zou JW; Wei W; Guo RP
    Mutagenesis; 2021 Oct; 36(5):369-379. PubMed ID: 34467992
    [TBL] [Abstract][Full Text] [Related]  

  • 33. N6-Methyladenosine RNA Methylation Regulator-Related Alternative Splicing (AS) Gene Signature Predicts Non-Small Cell Lung Cancer Prognosis.
    Zhao Z; Cai Q; Zhang P; He B; Peng X; Tu G; Peng W; Wang L; Yu F; Wang X
    Front Mol Biosci; 2021; 8():657087. PubMed ID: 34179079
    [TBL] [Abstract][Full Text] [Related]  

  • 34. N6-methyladenosine RNA methylation regulator-related alternative splicing gene signature as prognostic predictor and in immune microenvironment characterization of patients with low-grade glioma.
    Maimaiti A; Tuersunniyazi A; Meng X; Pei Y; Ji W; Feng Z; Jiang L; Wang Z; Kasimu M; Wang Y; Shi X
    Front Genet; 2022; 13():872186. PubMed ID: 35937991
    [No Abstract]   [Full Text] [Related]  

  • 35. Clinical and prognostic pan-cancer analysis of m6A RNA methylation regulators in four types of endocrine system tumors.
    Li K; Luo H; Luo H; Zhu X
    Aging (Albany NY); 2020 Nov; 12(23):23931-23944. PubMed ID: 33237039
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Contributions and Prognostic Values of N6-Methyladenosine RNA Methylation Regulators in Hepatocellular Carcinoma.
    Qi LW; Jia JH; Jiang CH; Hu JM
    Front Genet; 2020; 11():614566. PubMed ID: 33519919
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression and Prognostic Characteristics of m6A RNA Methylation Regulators in Colon Cancer.
    Huang L; Zhu J; Kong W; Li P; Zhu S
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33670062
    [TBL] [Abstract][Full Text] [Related]  

  • 38. m6A-Related Genes Contribute to Poor Prognosis of Hepatocellular Carcinoma.
    Zou Y; Jiang G; Xie Y; Li H
    Comput Math Methods Med; 2022; 2022():2427987. PubMed ID: 36339682
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analysis of Genetic Alteration Signatures and Prognostic Values of m6A Regulatory Genes in Head and Neck Squamous Cell Carcinoma.
    Zhou X; Han J; Zhen X; Liu Y; Cui Z; Yue Z; Ding L; Xu S
    Front Oncol; 2020; 10():718. PubMed ID: 32547941
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development and validation of a m
    Zhao X; Cui L
    Am J Cancer Res; 2019; 9(10):2156-2169. PubMed ID: 31720080
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.